INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 27, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 19,500 | -- | -- |
| Jun 21, 2021 |
Director, President and Chief Scientific
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 19,911 | $541.44 | 14,898 |
| May 01, 2012 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Open market or private sale of non-derivative or derivative security | 20,120 | $134.54 | 845,986 |
| Apr 13, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 20,326 | $24.60 | 98,379 |
| Dec 03, 2009 |
Director, EVP CSO & Pres Regn Res Labs
|
Director, EVP CSO & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 22,397 | $19.29 | 620,375 |
| Nov 18, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 23,367 | -- | 23,367 |
| Nov 18, 2019 |
Director, President and CSO
|
Director, President and CSO | Form 4 | Bona fide gift | 23,367 | -- | -- |
| Mar 06, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 23,367 | -- | -- |
| Mar 06, 2014 |
Director, President Regeneron Laboratori
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 23,367 | -- | 23,367 |
| Dec 01, 2011 |
Director, EVP CSO President Regeneron Re
|
Director, EVP CSO President Regeneron Re | Form 4 | Open market or private sale of non-derivative or derivative security | 24,413 | $59.45 | 899,270 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.